🔗 Visit the ClinicalTrials.gov page for NCT00169195
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. | N Engl J Med | 2002 | 19.60 |
| 2 | Supraadditive effect of 2',2'-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines. | Cancer Chemother Pharmacol | 1999 | 1.40 |
| 3 | An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma. | Br J Haematol | 2001 | 0.91 |
| 4 | Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma. | Ann Oncol | 2001 | 0.86 |
| 5 | Gemcitabine for relapsed or resistant lymphoma. | Ann Oncol | 2000 | 0.86 |
| 6 | Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial. | Haematologica | 2013 | 0.80 |